AOWM
HRTX icon

Alpha Omega Wealth Management’s Heron Therapeutics HRTX Stock Holding History

Alpha Omega Wealth Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-214
Closed -$5K – 632
2019
Q1 		$5K Buy
+214
New +$5.6K ﹤0.01% 487

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Alpha Omega Wealth Management's HRTX Position: Q2 2019 in Review

Alpha Omega Wealth Management sold out of Heron Therapeutics (HRTX) in Q2 2019, closing a stake of 214 shares — an estimated $5K sold.

Alpha Omega Wealth Management first reported a position in HRTX in Q1 2019 and held it in 1 quarter. The position peaked at $5K in Q1 2019. 176 funds tracked by Wall St. Rank hold HRTX as of Q2 2019.

  • Alpha Omega Wealth Management reported no remaining Heron Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Alpha Omega Wealth Management sold 214 Heron Therapeutics shares in Q2 2019, an estimated $5K.
  • Alpha Omega Wealth Management first reported a position in Heron Therapeutics in Q1 2019 and held it in 1 quarter.
  • Alpha Omega Wealth Management's Heron Therapeutics position peaked at $5K in Q1 2019.
  • 176 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q2 2019, filed 14 Aug 2019.